Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.

Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.

Show other versions (1)

<h4>Objectives</h4>Our study aims at comparing the efficacy and safety of IFN-based therapy (lopinavir/ritonavir, ribavirin, and interferon β-1b) vs. favipiravir (FPV) in a cohort of hospitalized patients with non-critical COVID-19.<h4>Methods</h4>Single center observational...

Full description

Bibliographic Details
Main Authors: Areej A Malhani, Mushira A Enani, Fatemeh Saheb Sharif-Askari, Mona R Alghareeb, Roaa T Bin-Brikan, Safar A AlShahrani, Rabih Halwani, Imad M Tleyjeh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0252984

Internet

https://doi.org/10.1371/journal.pone.0252984

Similar Items